Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide.
Gregori M, Taylor M, Salvati E, Re F, Mancini S, Balducci C, Forloni G, Zambelli V, Sesana S, Michael M, Michail C, Tinker-Mill C, Kolosov O, Sherer M, Harris S, Fullwood NJ, Masserini M, Allsop D. Gregori M, et al. Among authors: allsop d. Nanomedicine. 2017 Feb;13(2):723-732. doi: 10.1016/j.nano.2016.10.006. Epub 2016 Oct 19. Nanomedicine. 2017. PMID: 27769888 Free article.
Liposome delivery systems for the treatment of Alzheimer's disease.
Ross C, Taylor M, Fullwood N, Allsop D. Ross C, et al. Among authors: allsop d. Int J Nanomedicine. 2018 Dec 12;13:8507-8522. doi: 10.2147/IJN.S183117. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30587974 Free PMC article. Review.
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.
Parthsarathy V, McClean PL, Hölscher C, Taylor M, Tinker C, Jones G, Kolosov O, Salvati E, Gregori M, Masserini M, Allsop D. Parthsarathy V, et al. Among authors: allsop d. PLoS One. 2013;8(1):e54769. doi: 10.1371/journal.pone.0054769. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23382963 Free PMC article.
A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
El-Agnaf OM, Paleologou KE, Greer B, Abogrein AM, King JE, Salem SA, Fullwood NJ, Benson FE, Hewitt R, Ford KJ, Martin FL, Harriott P, Cookson MR, Allsop D. El-Agnaf OM, et al. Among authors: allsop d. FASEB J. 2004 Aug;18(11):1315-7. doi: 10.1096/fj.03-1346fje. Epub 2004 Jun 4. FASEB J. 2004. PMID: 15180968
182 results